Reprise Biomedical
Reprise Biomedical is a startup headquartered in Plymouth, United States, founded in 2019. It has raised at least $12.4m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Reprise Biomedical has raised at least $12.4m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Reprise Biomedical sits inside the Minneapolis region R&D ecosystem in the Global R&D Labs Directory.
Other startups in Plymouth
Related
- Innovation profile of Plymouth
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Reprise Biomedical do?
Reprise Biomedical is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Reprise Biomedical raised?
At least $12.4m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Reprise Biomedical based?
Reprise Biomedical is headquartered in Plymouth, United States.
When was Reprise Biomedical founded?
Reprise Biomedical was founded in 2019.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.